Sample size determination for point-of-care COVID-19 diagnostic tests: a Bayesian approach.

Williamson, S Faye; Williams, Cameron J; Lendrem, B Clare; Wilson, Kevin J

Williamson, S Faye; Williams, Cameron J; Lendrem, B Clare; Wilson, Kevin J.

Afiliação

Williamson SF; Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. faye.williamson@newcastle.ac.uk.
Williams CJ; NIHR Newcastle In Vitro Diagnostic Cooperative, Newcastle University, Newcastle upon Tyne, UK.
Lendrem BC; NIHR Newcastle In Vitro Diagnostic Cooperative, Newcastle University, Newcastle upon Tyne, UK.
Wilson KJ; School of Mathematics, Statistics and Physics, Newcastle University, Newcastle upon Tyne, UK.

Diagn Progn Res ; 7(1): 17, 2023 Aug 18.

Article em En | MEDLINE | ID: mdl-37596684

Palavras-chave

Bayesian assurance; COVID-19; Diagnostic accuracy study; Precision; Sample size; Sensitivity; Specificity

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Diagn Progn Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google